Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine versus placebo in hematopoietic stem cell transplant recipients
IRCT20100127003210N28Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in sleep disorder, anxiety disorder, major depressive disorder (MDD) and 2 more comparing Agomelatine with Placebo (2 arms). Primary endpoints: Pittsburgh Sleep Quality Index score, Council on Nutrition Appetite Questionnaire score and 2 more. Started Jul 2024; status: completed.
02
Drugs
agomelatine
03
Conditions
sleep disorderanxiety disordermajor depressive disorder (MDD)astheniaanorexia nervosa (AN)
Beyond the preview
Go deeper on IRCT20100127003210N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N28.